Binding of high-avidity anti-β2-glycoprotein I antibodies

被引:14
|
作者
Cucnik, S
Kveder, T
Rozman, B
Bozic, B
机构
[1] Univ Ljubljana, Med Ctr, Dept Rheumatol, Ljubljana 1000, Slovenia
[2] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia
关键词
anti-beta 2-glycoprotein I antibodies; Fab fragments; avidity; affinity; antiphospholipid syndrome; systemic lupus erythematosus;
D O I
10.1093/rheumatology/keh349
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. We studied the influence of different binding conditions on the interaction between high- or low-avidity IgG anti-beta(2)-glycoprotein I antibodies (anti-beta(2)-GPI) and beta(2)-GPI, which was either free in solution or bound to microtitre plates or nitrocellulose membranes. Methods. Sera from 30 patients with antiphospholipid syndrome and/or systemic lupus erythematosus were selected on the basis of anti-beta(2)-GPI positivity. Avidity of IgG anti-beta(2)-GPI was determined by chaotropic ELISA, using increased NaCl concentration during the antibody binding. Immunodetection on nitrocellulose membrane followed reducing or non-reducing sodium dodecyl sulphate-polyacrylamide gel electrophoresis (PAGE) of beta(2)-GPI. In converted, non-reducing PAGE, the preparation with high-affinity Fab fragments (obtained by papain digestion) was subjected to electrophoresis, while purified beta(2)-GPI was used as the sample in immunodetection. Results. Anti-beta(2)-GPI antibodies of high, low or heterogeneous (low and high) avidity were found in 5/30, 9/30 and 16/30 sera, respectively. The density of beta(2)-GPI, which was 20-30 times higher on the nitrocellulose membrane than on the surface of ELISA plates, was not sufficient for the recognition of the antigen by anti-beta(2)-GPI: 2/5 high-avidity samples reacted only with non-reduced beta(2)-GPI, 3/9 low-avidity samples recognized only denatured and reduced beta(2)-GPI, and 1/16 samples with heterogeneous-avidity antibodies reacted with reduced and non-reduced beta(2)-GPI. Conclusions. Our results suggest that neither high density of the antigen nor high avidity of the antibodies (or Fab fragments) alone was sufficient for the binding of anti-beta(2)-GPI to beta(2)-GPI. Some conformational modifications and, consequently, exposed neo-epitopes are required for the recognition of beta(2)-GPI by polyclonal anti-beta(2)-GPI antibodies.
引用
收藏
页码:1353 / 1356
页数:4
相关论文
共 50 条
  • [1] Optimization of Unnicked β2-Glycoprotein I and High Avidity Anti-β2-Glycoprotein I Antibodies Isolation
    Artenjak, Andrej
    Leonardi, Adrijana
    Krizaj, Igor
    Ambrozic, Ales
    Sodin-Semrl, Snezna
    Bozic, Borut
    Cucnik, Sasa
    JOURNAL OF IMMUNOLOGY RESEARCH, 2014, 2014 : 195687
  • [2] High-avidity anti-β2 glycoprotein I antibodies highly correlate with thrombosis in contrast to low-avidity anti-β2 glycoprotein I antibodies
    De Laat, B.
    Derksen, R. H. W. M.
    de Groot, P. G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (07) : 1619 - 1621
  • [3] Binding of high avidity anti-β2-glycoprotein I antibodies does not depend on antigen density
    Cucnik, S.
    Kveder, T.
    Rozman, B.
    Bozic, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A15 - A16
  • [4] High avidity anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome
    Cucnik, S
    Kverder, T
    Krizaj, I
    Roaman, B
    Bozic, B
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (11) : 1478 - 1482
  • [5] Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome
    Cucnik, S.
    Kveder, T.
    Artenjak, A.
    Gallova, Z. Ulcova
    Swadzba, J.
    Musial, J.
    Iwaniec, T.
    Stojanovich, L.
    Alessandri, C.
    Valesini, G.
    Avcin, T.
    Tervaert, J. W. Cohen
    Rozman, B.
    Bozic, B.
    LUPUS, 2012, 21 (07) : 764 - 765
  • [6] Anti-β2-glycoprotein I antibodies
    Willis, Rohan
    Pierangeli, Silvia S.
    YEAR IN IMMUNOLOGY, 2013, 1285 : 44 - 58
  • [7] Anti-β2-glycoprotein I antibodies
    Tsutsumi, A
    Ichikawa, K
    Matsuura, E
    Koike, T
    LUPUS, 1998, 7 : S98 - S102
  • [8] Immunochemical properties and pathological relevance of anti-β2-glycoprotein I antibodies of different avidity
    Zager, Urska
    Irman, Spela
    Lunder, Mojca
    Skarabot, Miha
    Musevic, Igor
    Hodnik, Vesna
    Anderluh, Gregor
    Cucnik, Sasa
    Kveder, Tanja
    Rozman, Blaz
    Bozic, Borut
    INTERNATIONAL IMMUNOLOGY, 2011, 23 (08) : 511 - 518
  • [9] IgA anti-?2-glycoprotein I antibodies
    Carrock Sewell
    Arthritis Research & Therapy, 3 (1)
  • [10] β2-glycoprotein I and anti-β2-glycoprotein I antibodies:: Where are we now?
    Inanç, M
    Radway-Bright, EL
    Isenberg, DA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (12): : 1247 - 1257